Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Human Genetics|September 28, 2005
Genetic prion disease: the EUROCJD experienceGábor G Kovács, Maria Puopolo, Anna Ladogana, et al.Acta Neuropathologica Communications|January 10, 2018
Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international studyIgnazio Cali, Mark L Cohen, Stephane Haik, et al.Neurobiology of Disease|April 26, 2026
Blood-based biomarkers of ferroptosis in Parkinson's diseaseVincent Huin, Emeline Cailliau, Clément Poupelin, et al.Parkinsonism & Related Disorders|March 26, 2026
Is being asymmetric a bad thing? Insights from a longitudinal observational study on STN-DBS Parkinson's diseaseRaquel Pinheiro Barbosa, Paulo Bastos, Matthieu Béreau, et al.Journal of Parkinson'S Disease|June 27, 2025
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's diseaseMathilde Boussac, Florent Faggianelli, Estelle Harroch, et al.NPJ Parkinson'S Disease|August 2, 2025
Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysisAymeric Lanore, Christelle Tesson, Aymeric Basset, et al.Plos One|April 29, 2015
A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease riskPascual Sanchez-Juan, Matthew T Bishop, Gabor G Kovacs, et al.Neurology|June 8, 2019
Age at onset in genetic prion disease and the design of preventive clinical trialsEric Vallabh Minikel, Sonia M Vallabh, Margaret C Orseth, et al.The Lancet. Neurology|January 14, 2014
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trialStéphane Haïk, Gabriella Marcon, Alain Mallet, et al.Science Translational Medicine|January 22, 2016
Quantifying prion disease penetrance using large population control cohortsEric Vallabh Minikel, Sonia M Vallabh, Monkol Lek, et al.Pageof 7